肝内胆管癌-话题@MedSci

#肝内胆管癌#

34篇内容 | 4178人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1296031, encodeId=b14d129603130, content=<a href='/topic/show?id=ef11811e363' target=_blank style='color:#2F92EE;'>#肝内胆管癌#</a>, objectTitle=Journal of Translational Medicine：专家绘制出基于中国人群肝内胆管癌“基因图谱” 致力精准施治, objectType=article, longId=198768, objectId=ea7b198e687d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ea7b198e687d, replyNumber=0, likeNumber=106, createdTime=2020-08-07, rootId=0, userName=liuxiaona, userId=cb3a261, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ea7b198e687d, moduleTitle=Journal of Translational Medicine：专家绘制出基于中国人群肝内胆管癌“基因图谱” 致力精准施治, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ea7b198e687d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1296030, encodeId=0078129603019, content=<a href='/topic/show?id=ef11811e363' target=_blank style='color:#2F92EE;'>#肝内胆管癌#</a>, objectTitle=JAMA Surg：肝内胆管癌根治性切除术后早期复发预测模型研究, objectType=article, longId=197522, objectId=629b19e52265, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=629b19e52265, replyNumber=0, likeNumber=0, createdTime=2020-07-16, rootId=0, userName=liuxiaona, userId=cb3a261, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=629b19e52265, moduleTitle=JAMA Surg：肝内胆管癌根治性切除术后早期复发预测模型研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=629b19e52265)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1296029, encodeId=b53f1296029a3, content=<a href='/topic/show?id=ef11811e363' target=_blank style='color:#2F92EE;'>#肝内胆管癌#</a>, objectTitle=Brit J Cancer：女性外源性激素和生殖因素与肝内胆管癌风险的关系, objectType=article, longId=193721, objectId=7155193e210d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7155193e210d, replyNumber=0, likeNumber=105, createdTime=2020-05-09, rootId=0, userName=liuxiaona, userId=cb3a261, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7155193e210d, moduleTitle=Brit J Cancer：女性外源性激素和生殖因素与肝内胆管癌风险的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7155193e210d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1296028, encodeId=79e412960285b, content=<a href='/topic/show?id=ef11811e363' target=_blank style='color:#2F92EE;'>#肝内胆管癌#</a>, objectTitle=AACR 2020：肝内胆管癌的FGFR2一个新型突变被发现, objectType=article, longId=193179, objectId=833e1931e9c2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=833e1931e9c2, replyNumber=0, likeNumber=127, createdTime=2020-05-01, rootId=0, userName=liuxiaona, userId=cb3a261, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=833e1931e9c2, moduleTitle=AACR 2020：肝内胆管癌的FGFR2一个新型突变被发现, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=833e1931e9c2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1296027, encodeId=0399129602e09, content=<a href='/topic/show?id=ef11811e363' target=_blank style='color:#2F92EE;'>#肝内胆管癌#</a>, objectTitle=肝内胆管癌靶向治疗首次重大突破！Pemigatinib横空出世, objectType=article, longId=189416, objectId=047d18941657, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=047d18941657, replyNumber=0, likeNumber=168, createdTime=2020-03-07, rootId=0, userName=liuxiaona, userId=cb3a261, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=047d18941657, moduleTitle=肝内胆管癌靶向治疗首次重大突破！Pemigatinib横空出世, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=047d18941657)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1296026, encodeId=9ee11296026ff, content=<a href='/topic/show?id=ef11811e363' target=_blank style='color:#2F92EE;'>#肝内胆管癌#</a>, objectTitle=Brit J Cancer：Nintedanib：肝内胆管癌的新福音——尼达尼布！, objectType=article, longId=187798, objectId=7c9018e79870, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7c9018e79870, replyNumber=0, likeNumber=110, createdTime=2020-02-12, rootId=0, userName=liuxiaona, userId=cb3a261, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7c9018e79870, moduleTitle=Brit J Cancer：Nintedanib：肝内胆管癌的新福音——尼达尼布！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7c9018e79870)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1296025, encodeId=97d5129602561, content=<a href='/topic/show?id=ef11811e363' target=_blank style='color:#2F92EE;'>#肝内胆管癌#</a>, objectTitle=Hepatology：ID3促进干细胞特征并预测肝内胆管癌的化疗反应, objectType=article, longId=164660, objectId=4d2816466030, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4d2816466030, replyNumber=0, likeNumber=92, createdTime=2019-04-22, rootId=0, userName=liuxiaona, userId=cb3a261, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4d2816466030, moduleTitle=Hepatology：ID3促进干细胞特征并预测肝内胆管癌的化疗反应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4d2816466030)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1296024, encodeId=0c4c129602489, content=<a href='/topic/show?id=ef11811e363' target=_blank style='color:#2F92EE;'>#肝内胆管癌#</a>, objectTitle=Eur J Gastroenterol Hepatol：肝硬化和患者的一般状况对肝内胆管癌的影响, objectType=article, longId=139533, objectId=a57d139533c1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a57d139533c1, replyNumber=0, likeNumber=97, createdTime=2018-06-01, rootId=0, userName=liuxiaona, userId=cb3a261, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a57d139533c1, moduleTitle=Eur J Gastroenterol Hepatol：肝硬化和患者的一般状况对肝内胆管癌的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a57d139533c1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1296023, encodeId=8486129602395, content=<a href='/topic/show?id=ef11811e363' target=_blank style='color:#2F92EE;'>#肝内胆管癌#</a>, objectTitle=J Hepatol：肝内胆管癌的时空演化, objectType=article, longId=133469, objectId=f66d133469b6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f66d133469b6, replyNumber=0, likeNumber=0, createdTime=2018-03-27, rootId=0, userName=liuxiaona, userId=cb3a261, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f66d133469b6, moduleTitle=J Hepatol：肝内胆管癌的时空演化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f66d133469b6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1296022, encodeId=c4ee1296022a1, content=<a href='/topic/show?id=ef11811e363' target=_blank style='color:#2F92EE;'>#肝内胆管癌#</a>, objectTitle=Lancet Gastroenterology& Hepatology：进行新辅助化疗病情稳定的肝内胆管癌患者再进行肝移植或可改善预后, objectType=article, longId=132567, objectId=ecde13256ebe, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ecde13256ebe, replyNumber=0, likeNumber=90, createdTime=2018-03-17, rootId=0, userName=liuxiaona, userId=cb3a261, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ecde13256ebe, moduleTitle=Lancet Gastroenterology& Hepatology：进行新辅助化疗病情稳定的肝内胆管癌患者再进行肝移植或可改善预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ecde13256ebe)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1296021, encodeId=da5d1296021cc, content=<a href='/topic/show?id=ef11811e363' target=_blank style='color:#2F92EE;'>#肝内胆管癌#</a>, objectTitle=Brit J Cancer：吸烟、饮酒与肝细胞癌以及肝内胆管癌风险之间的关系！, objectType=article, longId=132227, objectId=d5b413222ed1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d5b413222ed1, replyNumber=0, likeNumber=101, createdTime=2018-03-14, rootId=0, userName=liuxiaona, userId=cb3a261, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d5b413222ed1, moduleTitle=Brit J Cancer：吸烟、饮酒与肝细胞癌以及肝内胆管癌风险之间的关系！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d5b413222ed1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1296020, encodeId=a1c0129602025, content=<a href='/topic/show?id=ef11811e363' target=_blank style='color:#2F92EE;'>#肝内胆管癌#</a>, objectTitle=2018 ASCO-GI：仑伐替尼联合PD-1抑制剂治疗晚期肝内胆管癌疗效和安全性的初步研究, objectType=article, longId=127628, objectId=fb3d12e628a7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fb3d12e628a7, replyNumber=0, likeNumber=111, createdTime=2018-01-26, rootId=0, userName=liuxiaona, userId=cb3a261, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fb3d12e628a7, moduleTitle=2018 ASCO-GI：仑伐替尼联合PD-1抑制剂治疗晚期肝内胆管癌疗效和安全性的初步研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fb3d12e628a7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1296019, encodeId=d3171296019d2, content=<a href='/topic/show?id=ef11811e363' target=_blank style='color:#2F92EE;'>#肝内胆管癌#</a>, objectTitle=Hepatology：极早期肝内胆管癌或许不再是肝移植禁忌, objectType=article, longId=74599, objectId=981fe4599f3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=981fe4599f3, replyNumber=0, likeNumber=85, createdTime=2016-08-08, rootId=0, userName=liuxiaona, userId=cb3a261, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=981fe4599f3, moduleTitle=Hepatology：极早期肝内胆管癌或许不再是肝移植禁忌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=981fe4599f3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1296018, encodeId=ed321296018d1, content=<a href='/topic/show?id=ef11811e363' target=_blank style='color:#2F92EE;'>#肝内胆管癌#</a>, objectTitle=BMC Cancer：胆石症会大大增加肝内胆管癌风险, objectType=article, longId=58369, objectId=9d2d583695c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9d2d583695c, replyNumber=0, likeNumber=101, createdTime=2015-11-06, rootId=0, userName=liuxiaona, userId=cb3a261, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9d2d583695c, moduleTitle=BMC Cancer：胆石症会大大增加肝内胆管癌风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9d2d583695c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1296017, encodeId=f1f6129601ebb, content=<a href='/topic/show?id=ef11811e363' target=_blank style='color:#2F92EE;'>#肝内胆管癌#</a>, objectTitle=Nat Commun：肝内胆管癌的标识基因被揭示, objectType=article, longId=45382, objectId=400545382c5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=400545382c5, replyNumber=0, likeNumber=96, createdTime=2015-01-14, rootId=0, userName=liuxiaona, userId=cb3a261, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=400545382c5, moduleTitle=Nat Commun：肝内胆管癌的标识基因被揭示, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=400545382c5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1296016, encodeId=e16d1296016da, content=<a href='/topic/show?id=ef11811e363' target=_blank style='color:#2F92EE;'>#肝内胆管癌#</a>, objectTitle=利用个性化基因组信息成功治疗肝内胆管癌, objectType=article, longId=42483, objectId=dbe14248338, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dbe14248338, replyNumber=0, likeNumber=118, createdTime=2014-11-14, rootId=0, userName=liuxiaona, userId=cb3a261, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dbe14248338, moduleTitle=利用个性化基因组信息成功治疗肝内胆管癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dbe14248338)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1296015, encodeId=e9aa1296015b3, content=<a href='/topic/show?id=ef11811e363' target=_blank style='color:#2F92EE;'>#肝内胆管癌#</a>, objectTitle=ASO：可根据复发性肝内胆管癌瘤体大小选择再次手术切除或热消融治疗, objectType=article, longId=21185, objectId=c5c9211855f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c5c9211855f, replyNumber=0, likeNumber=81, createdTime=2013-07-13, rootId=0, userName=liuxiaona, userId=cb3a261, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c5c9211855f, moduleTitle=ASO：可根据复发性肝内胆管癌瘤体大小选择再次手术切除或热消融治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c5c9211855f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1296014, encodeId=d324129601464, content=<a href='/topic/show?id=ef11811e363' target=_blank style='color:#2F92EE;'>#肝内胆管癌#</a>, objectTitle=JCO：第二军医大学东方肝胆外科医院沈锋等建立的列线图模型可有效评估肝内胆管癌预后, objectType=article, longId=18594, objectId=44da18594b6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=44da18594b6, replyNumber=0, likeNumber=132, createdTime=2013-05-12, rootId=0, userName=liuxiaona, userId=cb3a261, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=44da18594b6, moduleTitle=JCO：第二军医大学东方肝胆外科医院沈锋等建立的列线图模型可有效评估肝内胆管癌预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=44da18594b6)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

肝内胆管癌

2020-05-29

liuxiaona (审核中...)

前往app查看评论内容

#肝内胆管癌#

Journal of Translational Medicine：专家绘制出基于中国人群肝内胆管癌“基因图谱” 致力精准施治

2020-08-07

liuxiaona (审核中...)

前往app查看评论内容

#肝内胆管癌#

JAMA Surg：肝内胆管癌根治性切除术后早期复发预测模型研究

2020-07-16

liuxiaona (审核中...)

前往app查看评论内容

#肝内胆管癌#

Brit J Cancer：女性外源性激素和生殖因素与肝内胆管癌风险的关系

2020-05-09

liuxiaona (审核中...)

前往app查看评论内容

#肝内胆管癌#

AACR 2020：肝内胆管癌的FGFR2一个新型突变被发现

2020-05-01

liuxiaona (审核中...)

前往app查看评论内容

#肝内胆管癌#

肝内胆管癌靶向治疗首次重大突破！Pemigatinib横空出世

2020-03-07

liuxiaona (审核中...)

前往app查看评论内容

#肝内胆管癌#

Brit J Cancer：Nintedanib：肝内胆管癌的新福音——尼达尼布！

2020-02-12

liuxiaona (审核中...)

前往app查看评论内容

#肝内胆管癌#

Hepatology：ID3促进干细胞特征并预测肝内胆管癌的化疗反应

2019-04-22

liuxiaona (审核中...)

前往app查看评论内容

#肝内胆管癌#

Eur J Gastroenterol Hepatol：肝硬化和患者的一般状况对肝内胆管癌的影响

2018-06-01

liuxiaona (审核中...)

前往app查看评论内容

#肝内胆管癌#

J Hepatol：肝内胆管癌的时空演化

2018-03-27

liuxiaona (审核中...)

前往app查看评论内容

#肝内胆管癌#

Lancet Gastroenterology& Hepatology：进行新辅助化疗病情稳定的肝内胆管癌患者再进行肝移植或可改善预后

2018-03-17

liuxiaona (审核中...)

前往app查看评论内容

#肝内胆管癌#

Brit J Cancer：吸烟、饮酒与肝细胞癌以及肝内胆管癌风险之间的关系！

2018-03-14

liuxiaona (审核中...)

前往app查看评论内容

#肝内胆管癌#

2018 ASCO-GI：仑伐替尼联合PD-1抑制剂治疗晚期肝内胆管癌疗效和安全性的初步研究

2018-01-26

liuxiaona (审核中...)

前往app查看评论内容

#肝内胆管癌#

Hepatology：极早期肝内胆管癌或许不再是肝移植禁忌

2016-08-08

liuxiaona (审核中...)

前往app查看评论内容

#肝内胆管癌#

BMC Cancer：胆石症会大大增加肝内胆管癌风险

2015-11-06

liuxiaona (审核中...)

前往app查看评论内容

#肝内胆管癌#

Nat Commun：肝内胆管癌的标识基因被揭示

2015-01-14

liuxiaona (审核中...)

前往app查看评论内容

#肝内胆管癌#

利用个性化基因组信息成功治疗肝内胆管癌

2014-11-14

liuxiaona (审核中...)

前往app查看评论内容

#肝内胆管癌#

ASO：可根据复发性肝内胆管癌瘤体大小选择再次手术切除或热消融治疗

2013-07-13

liuxiaona (审核中...)

前往app查看评论内容

#肝内胆管癌#

JCO：第二军医大学东方肝胆外科医院沈锋等建立的列线图模型可有效评估肝内胆管癌预后

2013-05-12

科室
- - 订阅+
  - 更多科室
工具
服务